[Federal Register: October 4, 2005 (Volume 70, Number 191)]
[Notices]
[Page 57878-57879]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr04oc05-70]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-05-05CZ]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-371-5983
and send comments to Seleda Perryman, CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Assessing Diabetes Detection Initiative for Policy Decisions--New--
National Center for Chronic Disease Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Type 2 diabetes is a chronic disease that affects more than 18
million Americans, approximately 5 million of whom do not know that
they have the disease. As the disease progresses, it often causes
severe complications, including heart disease, blindness, lower
extremity arterial disease, and kidney failure. Native Americans,
African Americans, Latino Americans, and some Asian Americans and
Pacific Islanders are disproportionately affected by diabetes.
Identifying persons who have undiagnosed diabetes and treating them
could prevent or delay diabetes complications.
In November 2003 the Diabetes Detection Initiative (DDI) was
launched in 10 pilot sites around the U.S. to identify a portion of the
estimated 5 million people with undiagnosed Type 2 diabetes, targeting
specific areas in each of 10 locales in which residents are likely to
be at higher risk for Type 2 diabetes. Implementation of the DDI
involved distributing a paper-and-pencil risk test. Individuals whose
score indicated that they were at an increased risk for diabetes were
advised to see their regular doctor (or to schedule an appointment at
one of several clinics that had agreed to participate in the DDI) to
receive a finger-stick or other tests to confirm whether or not they
have diabetes. Whether or not the DDI should be expanded to other
communities depends on the health benefits and costs of the program.
The CDC is planning to conduct a study to provide this critical
information.
The planned study will assess the resources used, the cost per case
detected, and the perceived benefit of the DDI to participants. Data
for the economic assessment will be obtained by conducting surveys of
local DDI implementation teams, leadership at participating health
clinics, and patients at participating health clinics. The results of
the study will also provide information needed for conducting a more
complete cost-effectiveness analysis of screening for undiagnosed
diabetes.
The point-of-contact (Implementation team member) in each of the 10
regions will be sent a mail survey to collect information regarding the
staff time and other resources used to implement the DDI program
(including the staff time and resources used by community-based
organizations that participated in the DDI implementation). These
planning and implementation activities include participating in
meetings and conference calls, recruiting clinics and community-based
organizations to participate in the DDI, distributing risk tests,
organizing health fairs and other community events, and designing media
campaigns to promote the DDI.
The health clinic leadership survey will be mailed to one person at
each of the 43 clinics that participated in the DDI implementation. The
survey will collect information regarding the costs associated with the
clinic's participation in the DDI. These will include the medical costs
of providing care to patients who visited the clinic as a result of the
DDI, staff time associated with DDI planning and implementation,
[[Page 57879]]
and any staff time that was devoted to performing finger stick tests at
locations other than the health clinic (e.g., health fairs, shopping
malls, work sites, housing complexes). Of the 43 clinics to be
surveyed, we expect that 30 (70%) will complete the survey.
A computer-assisted in-person interview will be administered to 600
clinic patients--60 in each of the 10 regions in which the pilot DDI
was implemented. The survey will collect background information, out-
of-pocket medical and non-medical direct health care costs (e.g., co-
payments, transportation costs, value of patients' time associated with
the clinic visit), and preferred features of a diabetes screening
program. There are no costs to respondents other than their time.
Estimate of Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Respondents Number of responses per per response Total burden
respondents respondent (in hours) hours
----------------------------------------------------------------------------------------------------------------
Implementation team members..................... 10 1 2 20
Clinic staff.................................... 30 1 1 30
Patients at DDI clinics......................... 600 1 20/60 200
-----------------
Total....................................... 640 .............. .............. 250
----------------------------------------------------------------------------------------------------------------
Dated: September 27, 2005.
Betsey Dunaway,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. 05-19827 Filed 10-3-05; 8:45 am]
BILLING CODE 4163-18-P